---
document_datetime: 2023-11-15 10:03:29
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/tractocile-epar-all-authorised-presentations_en.pdf
document_name: tractocile-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.026445
conversion_datetime: 2025-12-20 01:45:59.44327
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## ANNEX A

<div style=\"page-break-after: always\"></div>

| MA(EU)          | (Invented)   | Strength       | Pharmaceutical Form                   | Route of        | Immediate    | Content   | Pack   |
|-----------------|--------------|----------------|---------------------------------------|-----------------|--------------|-----------|--------|
| Number          | name         |                |                                       | administration  | Packaging    |           | size   |
| EU/1/99/124/001 | Tractocile   | 6,75 mg/0,9 ml | Solution for injection                | Intravenous use | vial (glass) | 0.9 ml    | 1 vial |
| EU/1/99/124/002 | Tractocile   | 37,5 mg/ 5 ml  | Concentrate for solution for infusion | Intravenous use | vial (glass) | 5 ml      | 1 vial |